Meta‐Analysis: Whither Narrative Review?

Meta‐analysis refers to methodologies that are used to integrate related empirical research to arrive at conclusions not possible by reviewing individual studies, or to improve generalizations of individual studies. It is distinguished from the traditional narrative review in that statistical methodologies are applied to derive more objective conclusions than those that typify narrative reviews. Meta‐analysis has been slow to appear in the literature of clinical medicine, however, particularly when viewed in the context of the exponential expansion of literature and the availability of computer technology to facilitiate its conduct.

[1]  Commentary on pooling the results of clinical trials , 1987 .

[2]  D W Fiske,et al.  The meta-analytic revolution in outcome research. , 1983, Journal of consulting and clinical psychology.

[3]  A. M. Walker,et al.  Odd man out: a graphical approach to meta-analysis. , 1988, American journal of public health.

[4]  T C Chalmers,et al.  Meta-analysis of clinical trials as a scientific discipline. II: Replicate variability and comparison of studies that agree and disagree. , 1987, Statistics in medicine.

[5]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[6]  Guidelines for evaluating new antimicrobial agents. , 1987, The Journal of infectious diseases.

[7]  J. Buring,et al.  Implications of overviews of randomized trials. , 1987, Statistics in medicine.

[8]  R. Wittes Problems in the medical interpretation of overviews. , 1987, Statistics in medicine.

[9]  R. Light,et al.  Accumulating evidence from independent studies: what we can win and what we can lose. , 1987, Statistics in medicine.

[10]  R. Rosenthal The file drawer problem and tolerance for null results , 1979 .

[11]  W. B. Fye The literature of American internal medicine: a historical view. , 1987, Annals of internal medicine.

[12]  S B Thacker,et al.  A proposal for more informative abstracts of review articles. , 1988, Annals of internal medicine.

[13]  H. Eysenck An exercise in mega-silliness. , 1978 .

[14]  T. Einarson,et al.  A Method for Meta-Analysis of Epidemiological Studies , 1988, Drug intelligence & clinical pharmacy.

[15]  W. Craig,et al.  Netilmicin Sulfate: A Comparative Evaluation of Antimicrobial Activity, Pharmacokinetics, Adverse Reactions and Clinical Efficacy , 1983, Pharmacotherapy.

[16]  M. Packer Clinical trials in congestive heart failure: why do studies report conflicting results? , 1988, Annals of internal medicine.

[17]  E. Veys,et al.  HL-A AND INFECTIVE SACROILEITIS , 1974 .

[18]  T. Cook,et al.  What differentiates meta-analysis from other forms of review? , 1981 .

[19]  R Collins,et al.  Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews. , 1987, Statistics in medicine.

[20]  P. Lietman,et al.  Aminoglycoside Nephrotoxicity in Humans , 1983 .

[21]  C B Begg,et al.  A measure to aid in the interpretation of published clinical trials. , 1985, Statistics in medicine.

[22]  T C Chalmers,et al.  Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials. , 1987, Statistics in medicine.

[23]  C. Mulrow The medical review article: state of the science. , 1987, Annals of internal medicine.

[24]  D. P. Hartmann,et al.  Meta-analysis: Techniques, applications, and functions. , 1983 .

[25]  R. Collins,et al.  Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. , 1985, European heart journal.

[26]  T. Chalmers,et al.  Meta-analyses of randomized controlled trials. , 1987, The New England journal of medicine.

[27]  R Peto,et al.  Why do we need systematic overviews of randomized trials? , 1987, Statistics in medicine.

[28]  J. Buring,et al.  Randomized trials of aminoglycoside antibiotics: quantitative overview. , 1988, Reviews of infectious diseases.

[29]  E. Huth,et al.  Needed: review articles with more scientific rigor. , 1987, Annals of internal medicine.

[30]  R. Horwitz,et al.  The experimental paradigm and observational studies of cause-effect relationships in clinical medicine. , 1987, Journal of chronic diseases.

[31]  J. Mintz,et al.  Integrating research evidence: a commentary on meta-analysis. , 1983, Journal of consulting and clinical psychology.

[32]  J. Tobin,et al.  Diagnostic heterogeneity in clinical trials for congestive heart failure. , 1988, Annals of internal medicine.

[33]  J C Bailar,et al.  Guidelines for statistical reporting in articles for medical journals. Amplifications and explanations. , 1988, Annals of internal medicine.

[34]  D L Demets,et al.  Methods for combining randomized clinical trials: strengths and limitations. , 1987, Statistics in medicine.

[35]  G. Glass,et al.  An apology for research integration in the study of psychotherapy. , 1983, Journal of consulting and clinical psychology.

[36]  C. Furberg,et al.  Lessons from overviews of cardiovascular trials. , 1987, Statistics in medicine.

[37]  T C Chalmers,et al.  A method for assessing the quality of a randomized control trial. , 1981, Controlled clinical trials.

[38]  T A Louis,et al.  Findings for public health from meta-analyses. , 1985, Annual review of public health.

[39]  K A L'Abbé,et al.  Meta-analysis in clinical research. , 1987, Annals of internal medicine.

[40]  S. Yusuf Obtaining medically meaningful answers from an overview of randomized clinical trials. , 1987, Statistics in medicine.

[41]  W. Mcghan,et al.  Meta-analysis: quantitative integration of independent research results. , 1985, American journal of hospital pharmacy.

[42]  G A Diamond,et al.  Clinical trials and statistical verdicts: probable grounds for appeal. , 1983, Annals of internal medicine.

[43]  Cone La A survey of prospective, controlled clinical trials of gentamicin, tobramycin, amikacin, and netilmicin. , 1982 .

[44]  S B Thacker,et al.  Meta-analysis. A quantitative approach to research integration. , 1988, JAMA.

[45]  L. Bolognese,et al.  RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2 , 1988, The Lancet.